Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Publish with us
About the journal
Meet the editors
Specialist reviews
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Publish with us
About the journal
Meet the editors
Specialist reviews
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Drug therapy
Email alerts
Drug therapy
New and emerging treatments for myasthenia gravis
Mckenzye
DeHart-McCoyle
,
Shital
Patel
,
Xinli
Du
BMJ Medicine
Aug 2023,
2
(1)
e000241;
DOI:
10.1136/bmjmed-2022-000241
Quality of reporting of adverse events in clinical trials of covid-19 drugs: systematic review
Karima
Madi
,
Clara
Flumian
,
Pascale
Olivier
,
Agnès
Sommet
,
François
Montastruc
BMJ Medicine
Aug 2023,
2
(1)
e000352;
DOI:
10.1136/bmjmed-2022-000352
Evidence at time of regulatory approval and cost of new antibiotics in 2016-19: cohort study of FDA approved drugs
Mayookha
Mitra-Majumdar
,
John H
Powers
,
Beatrice L
Brown
,
Aaron S
Kesselheim
BMJ Medicine
Dec 2022,
1
(1)
e000227;
DOI:
10.1136/bmjmed-2022-000227
Vibration of effect in more than 16 000 pooled analyses of individual participant data from 12 randomised controlled trials comparing canagliflozin and placebo for type 2 diabetes mellitus: multiverse analysis
Henri
Gouraud
,
Joshua D
Wallach
,
Rémy
Boussageon
,
Joseph S
Ross
,
Florian
Naudet
BMJ Medicine
Sep 2022,
1
(1)
e000154;
DOI:
10.1136/bmjmed-2022-000154
No terms available for